Radiation oncology firm Varian Medical Systems reported sales of $171 million in its fiscal third quarter, up 18% compared with the $145 million reported in the same period in 1999. For the period (end-June 30), the Palo Alto, CA-based vendor had net income of $14 million, compared with pro forma net income of $10.9 million in the third quarter of 1999.
Varian’s solid performance was due to strong demand for advanced radiotherapy systems -- particularly in North America -- and substantial increases in sales of its new high-power x-ray tube, according to president and CEO Richard Levy.
By AuntMinnie.com staff writers
July 27, 2000
Related Reading
Varian debuts IMRT QA software, July 25, 2000.
Varian to buy IMPAC Medical Systems, June 7, 2000.
FDA OKs Varian’s brachytherapy software, May 10, 2000.
Varian results climb in first quarter, April 26, 2000.
Varian gets clearance for SomaVision software, March 10, 2000.
